StockWatch
·

SANDU PHARMACEUTICALS LTD. Q1 FY26 Results

SANDUPHQQ1 FY26 Results
Filing
MetricValue (₹ Cr)vs Q4 FY25
Revenue16.7018.7%
Total Income16.7218.2%
Expenditure16.3818.7%
PBT0.341.1%
Net Profit0.2231.6%
OPM3.14%0.04pp
NPM1.34%0.97pp
EPS0.2332.4%
View full financials

Informational and educational content only. Not investment advice.